Alvotech, a privately-owned biopharmaceutical company out of Reykjavik, Iceland, announced a partnership with Cipla Gulf FZ LLC for the commercialization of a biosimilar (AVT02 – an adalimumab biosimilar) in emerging markets. AVT02 is a biosimilar to AbbVie’s Humira with indications for several autoimmune diseases, such as Rheumatoid Arthritis. In...
Mentis Cura, an Icelandic-Norwegian health technology company, begins marketing in Japan through partnership with Nihon Medi-Physics out of Japan. The partnership is valued at over 112.4-million USD (14-billion ISK) over the next 10 years. The partnership will enable the core products to be marketed in Japan following successful clinical trials and...
The Central Bank of Iceland has published a new working paper on the interaction between inflation and long-term inflation expectations at the Central Bank’s inflation target. This paper is a revised and updated version of Working Paper No. 77 that was published in March 2018.
The Central Bank of Iceland conducted its survey of market agents’ expectations during the period 12-14 August 2019. A total of 28 agents in the bond market, including banks, pension funds, mutual and investment funds, securities brokers, and licensed asset management firms were invited to participate. Responses were received from 24 market partici...
For further information on the benefits of establishing a business in Iceland please feel free to contact us.